Fiscal Year Ended 2025/3

• 2025-02-13
  Notice Concerning Commencement of New Business
• 2025-02-13
  Notice Concerning Revision of Forecast of Financial Results
• 2024-11-21
  Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2024

Fiscal Year Ended 2024/3

• 2023-11-24
  Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2023
• 2023-11-13
  Notice of Revision of Forecast of Financial Results (Upward Revision)
• 2023-11-13
  Notice of Additional Investment in Cambrian, Inc.

Fiscal Year Ended 2023/3

• 2023-03-10
  Notice of Changes in Representative Directors’ Positions, Organization and Personnel
• 2022-11-21
  Transcript including Q&As of the Results Briefing for the second quarter ended September 30, 2022
• 2022-4-13
  Notice of Additional Order of RS1

Fiscal Year Ended 2022/3

• 2022-02-10
  Notice of Large-scale Order
• 2021-11-10
  Notice of Revision of Forecast of Financial Results
• 2021-10-12
  Business Plan and Growth Potential
• 2021-10-12
  Notice of Application for Selection of New Market Segment “Growth Market”

• 2021-09-03
  Presentation for IR Seminar for Personal Investors on August 28, 2021
• 2021-08-11
  Notice of Large-scale Order
• 2021-05-14
  Notice of Medium-term Business Plan
• 2021-04-09
  Notice of Capital and Business Alliance with Cambrian, Inc.
• 2021-04-09
  Notice of Medium-term Business Direction

Fiscal Year Ended 2021/3

• 2021-04-09
  Notice of Revision of Forecast of Financial Results
• 2020-05-12
  Notice of changes in representative director and directors and personnel change
• 2020-05-12
  Notice of Introduction of Restricted Stock Compensation System
• 2020-05-12
  Notice of partial amendment to the Articles of Incorporation
• 2020-04-10
  Notice of Revision of Forecast of Financial Results